Pfizer Nabs Majority Stake In Swiss Vaccine Manufacturer
Pfizer Inc. has added to its research portfolio with the acquisition of a controlling interest in a Swiss company developing a vaccine for a herpes virus that is often dangerous to...To view the full article, register now.
Already a subscriber? Click here to view full article